JONES FINANCIAL COMPANIES LLLP
Position in RGC — Regencell Bioscience Holdings Ltd
CIK 815917
DES PERES, MO
Position in RGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$602
New position
Shares Held
99
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 35 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 59%
Shared 0%
None 41%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $116,301,284 across 50 Drug Manufacturers - Specialty & Generic names. RGC ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
7,116,095 | $66,393,166 | |
| 2 | ZTS |
Zoetis Inc.
|
191,729 | $13,777,645 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
332,250 | $11,256,629 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
179,743 | $8,496,451 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
33,495 | $5,645,247 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
4,777 | $2,588,321 | |
| 7 | VTRS |
Viatris Inc
|
136,476 | $2,167,238 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
110,479 | $1,912,391 |
All Filings in RGC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $602 | 99 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||